Target intelligence / Profile preview

Gap junction alpha-1 protein–microtubule interface (Cx43–MT interface) (Cx43–MT interface)

Target
Cx43–MT interface
Molecular classification
Protein-protein interface, Gap junction protein, Cytoskeletal component
01

Overview

Gap junction alpha-1 protein (Connexin 43 or Cx43) is a critical transmembrane protein that forms hemichannels and gap junctions, facilitating electrical and chemical coupling between cells, particularly in the ventricular myocardium (UniProt P17302). The Cx43–microtubule interface refers to the specific protein-protein interaction between the C-terminal tail of Cx43 and the microtubule network, which serves as a highway for the delivery of newly synthesized Cx43 to the plasma membrane (Shaw et al., 2007, Cell). This trafficking process is essential for maintaining the high density of gap junctions at intercalated discs required for rapid cardiac conduction. In pathological states like myocardial infarction or heart failure, this interface is often compromised, leading to the lateralization of Cx43 and subsequent arrhythmogenesis (Smyth et al., 2010, Journal of Cell Science). Therapeutic strategies targeting this interface, such as the JM2 peptide, aim to modulate Cx43-tubulin binding to prevent the sequestration of Cx43 in the cytoplasm or its mislocalization to lateral membranes, thereby preserving cardiac rhythm and reducing the risk of sudden cardiac death (Basheer et al., 2017, JACC: Basic to Translational Science). Beyond the heart, this interface is also a subject of interest in wound healing and oncology, where Cx43-mediated communication influences cell migration and tissue repair.

Other names
Connexin 43–microtubule interactionGJA1–tubulin binding siteCx43–TBD interactionConnexin 43–tubulin interface
02

Mechanism of action

Modulation of the protein-protein interaction between the Connexin 43 C-terminal tubulin-binding domain and microtubules to regulate gap junction hemichannel trafficking and assembly.

03

Biological functions

Intracellular traffickingGap junction assemblyCell-to-cell communicationElectrical coupling
04

Disease associations

Cardiovascular diseaseCardiac arrhythmiaHeart failureWound healing
05

Safety considerations

Potential disruption of general microtubule-dependent transportSystemic gap junction disruption in non-target tissuesRisk of unintended changes in cellular signaling pathways
06

Interacting drugs

JM2 peptide

1 more in the full profile.

07

Biomarkers

Cx43 membrane localizationGap junction density at intercalated discsQRS durationCx43 phosphorylation status

Beyond the preview

Go deeper on Gap junction alpha-1 protein–microtubule interface (Cx43–MT interface) (Cx43–MT interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gap junction alpha-1 protein–microtubule interface (Cx43–MT interface) (Cx43–MT interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call